| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-05 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
4e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-05 |